论文信息 - CYP1A2 F21L and F186L polymorphisms in an Italian population sample.

CYP1A2 F21L and F186L polymorphisms in an Italian population sample.

P450 cytochromes (CYPs) enzymes play a major role in variability of drug response and cancer susceptibility. In particular, up to 60-fold interindividual variation has been detected in the activity of CYP1A2, which is involved in the metabolism of caffeine, several drugs and various toxic and carcinogenic compounds. Aim of this study is to assess the frequency of CYP1A2 F21L and F186L polymorphisms (formerly CYP1A2(*)2 and (*)11 alleles), up to now found in Asiatic populations only. These variants were absent in 500 Italian healthy subjects. Therefore it can be suggested that the variation of CYP1A2-dependent metabolism in the Caucasian population is not related to these two CYP1A2 polymorphisms. Thus, this study supports the view that ethnicity is a relevant factor to be carefully considered in pharmacogenetic studies.

[1] R. V. Schaik. Cancer treatment and pharmacogenetics of cytochrome P450 enzymes , 2005, Investigational New Drugs.

[2] M. Nakajima,et al. Cytochrome P450-mediated metabolism of estrogens and its regulation in human. , 2005, Cancer letters.

[3] Kazuo Komamura,et al. Six Novel Nonsynonymous CYP1A2 Gene Polymorphisms: Catalytic Activities of the Naturally Occurring Variant Enzymes , 2004, Journal of Pharmacology and Experimental Therapeutics.

[4] D. Nebert,et al. Uroporphyrin accumulation in hepatoma cells expressing human or mouse CYP1A2: relation to the role of CYP1A2 in human porphyria cutanea tarda. , 2003, Biochemical pharmacology.

[5] H. Yamazaki,et al. A population phenotyping study of three drug‐metabolizing enzymes in Kyushu, Japan, with use of the caffeine test , 2002, Clinical pharmacology and therapeutics.

[6] K. Kyvik,et al. The interindividual differences in the 3-demthylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors. , 2002, Pharmacogenetics.

[7] J. Barrett,et al. Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism. , 2003, British journal of clinical pharmacology.

[8] M. Lai,et al. Detection of a novel cytochrome P-450 1A2 polymorphism (F21L) in Chinese. , 1999, Drug metabolism and disposition: the biological fate of chemicals.